Analyst Ratings for Millendo Therapeutics Inc. (MLND)

MLND Rating Summary

  |   Expand Research on MLND
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 4.3 / 10   Percentile Rank: 43%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/6/2021 Ladenburg Thalmann Matthew Kaplan Downgrade Neutral
(Buy)		 N/A
(N/A)		 1.69
(1.06)		 -37.28% Details
1/6/2021 Leerink Joseph Schwartz Downgrade Market Perform
(Outperform)		 2.00
(N/A)		 2.06
(1.06)		 -48.54% Details